Legal-Malpractice, Mesothelioma / 25.03.2025

Mesothelioma is a rare and aggressive cancer primarily caused by asbestos exposure, making legal assistance crucial for affected individuals. Navigating the complexities of legal options can be daunting, but it's essential for securing compensation. This guide provides insights into understanding the legal process and the importance of timely action. Mesothelioma, often linked to asbestos exposure in workplaces, demands specialized legal attention. As someone affected by this condition, you need to understand the intricacies of the legal process that can help you seek justice and compensation. The role of mesothelioma attorney assistance cannot be understated, as experienced lawyers guide you through the lawsuit maze. This article aims to empower you with knowledge about your legal rights and options. (more…)
Legal-Malpractice, Mesothelioma / 19.03.2025

Mesothelioma is a devastating cancer linked to asbestos exposure, affecting many each year. Victims often face overwhelming medical and financial burdens, making legal avenues a crucial consideration. Understanding the available options can empower patients and their families to seek justice and compensation. Mesothelioma is a rare but aggressive form of cancer primarily caused by prolonged exposure to asbestos fibers. This disease often manifests years after initial exposure, leaving many unaware of its impending threat. As the medical community continues to search for effective treatments, understanding the legal pathways becomes essential for patients seeking compensation. Legal recourse offers a means to address not only the medical expenses but also the emotional and financial turmoil faced by affected individuals and their families. Engaging with top rated mesothelioma lawyers can significantly enhance your ability to understand and pursue these legal avenues effectively. (more…)
AACR, Author Interviews, Cancer Research, Genetic Research, NIH / 23.04.2021

MedicalResearch.com Interview with: Nishanth Ulhas Nair, Ph.D. Affiliation: Staff Scientist at Cancer Data Science Laboratory, Center for Cancer Research National Cancer Institute (NCI), National Institutes of Health (NIH) Bethesda, Maryland, USA. Date: April 22, 2021 Dr. Raffit Hassan and Dr. Eytan Ruppin at the National Cancer Institute (NCI) are the senior authors of this study.  MedicalResearch.com: What is the background for this study? Response: Malignant mesothelioma is an aggressive cancer with limited treatment options and poor prognosis. An in-depth knowledge of genetic, transcriptomic and immunogenic events involved in mesothelioma is critical for successful development of prognostics and therapeutic modalities. In this study we aim to address this by exploring a new large scale patient tumor dataset of 122 mesothelioma patients, called NCI mesothelioma patient data, along with their genomic, transcriptomic, and phenotypic information. Unlike previous large-scale studies which have been focused on malignant pleural mesothelioma patients, our dataset contains an approximately equal representation of malignant pleural and peritoneal mesothelioma patients which allows to identify any differences between them. (more…)